Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The Ensign Group, Inc is a medical care facilities business based in the US. The Ensign Group shares (ENSG) are listed on the NASDAQ and all prices are listed in US Dollars. The Ensign Group employs 24,500 staff and has a trailing 12-month revenue of around USD$2.3 billion.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Mobile users
Latest market close | USD$75.9 |
---|---|
52-week range | USD$23.9725 - USD$77.27 |
50-day moving average | USD$71.0868 |
200-day moving average | USD$56.6527 |
Wall St. target price | USD$69.75 |
PE ratio | 26.7721 |
Dividend yield | USD$0.21 (0.29%) |
Earnings per share (TTM) | USD$2.72 |
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $75.9 from 2020-12-09
1 week (2021-01-07) | -11.11% |
---|---|
1 month (2020-12-17) | 2.04% |
3 months (2020-10-16) | 30.82% |
6 months (2020-07-17) | 67.44% |
1 year (2020-01-17) | 59.69% |
---|---|
2 years (2019-01-17) | 78.31% |
3 years (2018-01-17) | 223.08% |
5 years (2016-01-15) | 257.12% |
Valuing The Ensign Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Ensign Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Ensign Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, The Ensign Group shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
The Ensign Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3756. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Ensign Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Ensign Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$260 million.
The EBITDA is a measure of a The Ensign Group's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | USD$2.3 billion |
---|---|
Operating margin TTM | 8.87% |
Gross profit TTM | USD$291.1 million |
Return on assets TTM | 5.36% |
Return on equity TTM | 20.79% |
Profit margin | 6.49% |
Book value | $14.284 |
Market capitalisation | USD$3.9 billion |
TTM: trailing 12 months
There are currently 802,509 The Ensign Group shares held short by investors – that's known as The Ensign Group's "short interest". This figure is 4.2% up from 769,914 last month.
There are a few different ways that this level of interest in shorting The Ensign Group shares can be evaluated.
The Ensign Group's "short interest ratio" (SIR) is the quantity of The Ensign Group shares currently shorted divided by the average quantity of The Ensign Group shares traded daily (recently around 218667.30245232). The Ensign Group's SIR currently stands at 3.67. In other words for every 100,000 The Ensign Group shares traded daily on the market, roughly 3670 shares are currently held short.
However The Ensign Group's short interest can also be evaluated against the total number of The Ensign Group shares, or, against the total number of tradable The Ensign Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Ensign Group's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 The Ensign Group shares in existence, roughly 20 shares are currently held short) or 0.0269% of the tradable shares (for every 100,000 tradable The Ensign Group shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Ensign Group.
Find out more about how you can short The Ensign Group stock.
Dividend payout ratio: 6.91% of net profits
Recently The Ensign Group has paid out, on average, around 6.91% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Ensign Group shareholders could enjoy a 0.29% return on their shares, in the form of dividend payments. In The Ensign Group's case, that would currently equate to about $0.21 per share.
While The Ensign Group's payout ratio might seem low, this can signify that The Ensign Group is investing more in its future growth.
The Ensign Group's most recent dividend payout was on 31 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2020 (the "ex-dividend date").
The Ensign Group's shares were split on a 1069:1000 basis on 1 October 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1069 shares. This wouldn't directly have changed the overall worth of your The Ensign Group shares – just the quantity. However, indirectly, the new 6.5% lower share price could have impacted the market appetite for The Ensign Group shares which in turn could have impacted The Ensign Group's share price.
Over the last 12 months, The Ensign Group's shares have ranged in value from as little as $23.9725 up to $77.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Ensign Group's is 1.0598. This would suggest that The Ensign Group's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company offers transitional and skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly. It also provides standard services, such as room and board, special nutritional program, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of December 31, 2019, it operated 223 skilled nursing and senior living facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Massachusetts, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The Ensign Group, Inc. was founded in 1999 and is based in San Juan Capistrano, California.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.